Latest AI and machine learning research in hepatitis for healthcare professionals.
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease, while non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, which can progress to more severe liver diseases such as liver fibrosis, cirrhosis and hepatocellular carcinoma. Approximately 50%-70% of T2DM patients also have NAFLD. Traditional diagnostic methods like liver biopsy have limitations, making ...
BACKGROUND: Metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis is a leading indication for liver transplantation (LT). Patients with MASH cirrhosis are complex and often have extensive comorbidities. The current model for end-stage liver disease (MELD)-based liver allocation system has suboptimal concordance in predicting waitlist mortality for patients with MASH cirrhosis. Furtherm...
An accurate and precise normalization procedure is essential to correct for variations in detector efficiency in reconstructed positron emission t...
BACKGROUND: In positron emission tomography (PET), gamma photons arriving at the detector ring may undergo one or more Compton scattering events, pote...
Nanotechnology serves as a nanoscale interface that directly bridges our perception of the macroscopic world with the intricate nanoworld where indivi...
BACKGROUND: Complete virological response (CVR) is the primary goal of nucleos(t)ide analogues (NAs) therapy for chronic hepatitis B (CHB) patients. T...
BACKGROUND: The development of a single therapeutic compound can exceed 1.8 billion USD and take more than a decade, underscoring the urgent need to a...
Large Language Models for Code (LLMs4Code) have achieved strong performance in code generation, but recent studies reveal that they may memorize and l...
BACKGROUND & AIMS: HBV covalently closed circular DNA (cccDNA) and HBV-integrated DNA (iDNA) are features of chronic HBV (CHB). Elimination of both ce...
BACKGROUND & AIMS: Alcohol abstinence enables hepatic recompensation in patients with decompensated alcohol-related cirrhosis. This study investigated...
This study aimed to identify shared diagnostic biomarkers and common immune mechanisms between systemic lupus erythematosus (SLE) and psoriasis (PSO) ...
In the present work, a structural model for the protein-protein interface of bone marrow stromal cell antigen 2 (BST-2) and severe acute respiratory s...
Acute-on-chronic liver failure is a complex condition with varied definitions, complicating risk stratification and targeted management. We apply unsu...
Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality, yet the role of N-glycosylation in its pathogenesis remains unclear. We applied...
PURPOSE OF REVIEW: Recent advances in artificial intelligence (AI) coincide with decreases in confidence in vaccines. This review examines studies tha...
BACKGROUND: Fatty liver disease is a common condition linked to metabolic syndrome, cardiovascular diseases, and liver cirrhosis, and timely, accurate...
Metabolic dysfunction-associated steatohepatitis (MASH) is a global health care burden. Appropriate large animal models mimicking the main MASH charac...
BACKGROUND: Current liver cancer screening in Korea focuses on viral hepatitis or cirrhosis, despite rising risks from metabolic and alcohol-related l...
Staphylococcus aureus is a leading cause of nosocomial infections, including sepsis, bacteraemia, pneumonia, and endocarditis, and continues to pose a...
Objective Magnetic resonance imaging (MRI)-only proton therapy combines high soft tissue contrast with high-precision dose distributions. However,...